Neurological adverse events of blinatumomab in children with B-cell acute lymphoblastic leukemia: a retrospective study
Yuan-Yuan Zeng, Yong Zhang, Feng Chen, Yong-Jun Fang · 2026
Read Neurological adverse events of blinatumomab in children with B-cell acute lymphoblastic leukemia: a retrospective study by Yuan-Yuan Zeng, Yong Zhang, Feng Chen, Yong-Jun Fang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13471404.txt.
Description
Yuan-Yuan Zeng, Yong Zhang, Feng Chen, and Yong-Jun Fang review in 2026 the nerve side effects of a leukemia drug in children treated at their hospital. Blinatumomab helps children with B cell acute lymphoblastic leukemia, yet its effects on the nervous system in real practice needed mapping. Records covered sixty children treated across two years, with every neurological event logged by timing, severity, management, and outcome.
Thirteen children had eighteen events between them, mostly headache, dizziness, tremor, and confusion. Most events struck during the first treatment cycle, at a median of about nine days in, and lasted under three days. Nearly nine in ten were mild or moderate. Two children suffered grade four events, one with prolonged seizures and one with brain herniation. Older age independently predicted these events.
Catalog record
| CREATOR | Yuan-Yuan Zeng, Yong Zhang, Feng Chen, Yong-Jun Fang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28306 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |